139 related articles for article (PubMed ID: 24315924)
1. Use of heat of adsorption to quantify amorphous content in milled pharmaceutical powders.
Alam S; Omar M; Gaisford S
Int J Pharm; 2014 Jan; 459(1-2):19-22. PubMed ID: 24315924
[TBL] [Abstract][Full Text] [Related]
2. Following mechanical activation of salbutamol sulphate during ball-milling with isothermal calorimetry.
Gaisford S; Dennison M; Tawfik M; Jones MD
Int J Pharm; 2010 Jun; 393(1-2):74-8. PubMed ID: 20385222
[TBL] [Abstract][Full Text] [Related]
3. Approaches to determine the enthalpy of crystallisation, and amorphous content, of lactose from isothermal calorimetric data.
Dilworth SE; Buckton G; Gaisford S; Ramos R
Int J Pharm; 2004 Oct; 284(1-2):83-94. PubMed ID: 15454300
[TBL] [Abstract][Full Text] [Related]
4. A novel method for the production of crystalline micronised particles.
Muhammad SA; Langrish T; Tang P; Adi H; Chan HK; Kazarian SG; Dehghani F
Int J Pharm; 2010 Mar; 388(1-2):114-22. PubMed ID: 20043982
[TBL] [Abstract][Full Text] [Related]
5. The use of MTDSC to assess the amorphous phase content of a micronized drug substance.
Guinot S; Leveiller F
Int J Pharm; 1999 Dec; 192(1):63-75. PubMed ID: 10572200
[TBL] [Abstract][Full Text] [Related]
6. The development of DMA for the detection of amorphous content in pharmaceutical powdered materials.
Royall PG; Huang CY; Tang SW; Duncan J; Van-de-Velde G; Brown MB
Int J Pharm; 2005 Sep; 301(1-2):181-91. PubMed ID: 16026947
[TBL] [Abstract][Full Text] [Related]
7. Calorimetric determination of amorphous content in lactose: a note on the preparation of calibration curves.
Ramos R; Gaisford S; Buckton G
Int J Pharm; 2005 Aug; 300(1-2):13-21. PubMed ID: 16009516
[TBL] [Abstract][Full Text] [Related]
8. Isothermal microcalorimetry for quantifying amorphous content in processed pharmaceuticals.
Gaisford S
Adv Drug Deliv Rev; 2012 Apr; 64(5):431-9. PubMed ID: 22100528
[TBL] [Abstract][Full Text] [Related]
9. Assessing the re-crystallization behaviour of amorphous lactose using the RH-perfusion cell.
Timmermann IL; Steckel H; Trunk M
Eur J Pharm Biopharm; 2006 Aug; 64(1):107-14. PubMed ID: 16527465
[TBL] [Abstract][Full Text] [Related]
10. Influence of polymer content on stabilizing milled amorphous salbutamol sulphate.
Balani PN; Wong SY; Ng WK; Widjaja E; Tan RB; Chan SY
Int J Pharm; 2010 May; 391(1-2):125-36. PubMed ID: 20211717
[TBL] [Abstract][Full Text] [Related]
11. Repurposing Melt Degradation for the Evaluation of Mixed Amorphous-Crystalline Blends.
Abdul-Jabbar S; Wong DW; Martin GP; Woodhead B; Royall PG
AAPS PharmSciTech; 2021 Mar; 22(3):105. PubMed ID: 33718988
[TBL] [Abstract][Full Text] [Related]
12. A study of the crystallisation of amorphous salbutamol sulphate using water vapour sorption and near infrared spectroscopy.
Columbano A; Buckton G; Wikeley P
Int J Pharm; 2002 Apr; 237(1-2):171-8. PubMed ID: 11955815
[TBL] [Abstract][Full Text] [Related]
13. The quantification of small degrees of disorder in lactose using solution calorimetry.
Hogan SE; Buckton G
Int J Pharm; 2000 Oct; 207(1-2):57-64. PubMed ID: 11036230
[TBL] [Abstract][Full Text] [Related]
14. The potential of high speed DSC (hyper-DSC) for the detection and quantification of small amounts of amorphous content in predominantly crystalline samples.
Saunders M; Podluii K; Shergill S; Buckton G; Royall P
Int J Pharm; 2004 Apr; 274(1-2):35-40. PubMed ID: 15072780
[TBL] [Abstract][Full Text] [Related]
15. Rapid assessment of the structural relaxation behavior of amorphous pharmaceutical solids: effect of residual water on molecular mobility.
Miller DP; Lechuga-Ballesteros D
Pharm Res; 2006 Oct; 23(10):2291-305. PubMed ID: 16955371
[TBL] [Abstract][Full Text] [Related]
16. A microcalorimetric investigation of the interaction of surfactants with crystalline and partially crystalline salbutamol sulphate in a model inhalation aerosol system.
Blackett PM; Buckton G
Pharm Res; 1995 Nov; 12(11):1689-93. PubMed ID: 8592671
[TBL] [Abstract][Full Text] [Related]
17. Physicochemical and in vitro deposition properties of salbutamol sulphate/ipratropium bromide and salbutamol sulphate/excipient spray dried mixtures for use in dry powder inhalers.
Corrigan DO; Corrigan OI; Healy AM
Int J Pharm; 2006 Sep; 322(1-2):22-30. PubMed ID: 16815654
[TBL] [Abstract][Full Text] [Related]
18. Quantification of low levels of amorphous content in crystalline celecoxib using dynamic vapor sorption (DVS).
Sheokand S; Modi SR; Bansal AK
Eur J Pharm Biopharm; 2016 May; 102():77-86. PubMed ID: 26948976
[TBL] [Abstract][Full Text] [Related]
19. Antisolvent crystallisation is a potential technique to prepare engineered lactose with promising aerosolisation properties: effect of saturation degree.
Kaialy W; Nokhodchi A
Int J Pharm; 2012 Nov; 437(1-2):57-69. PubMed ID: 22884837
[TBL] [Abstract][Full Text] [Related]
20. Application and use of isothermal calorimetry in pharmaceutical development.
O'Neill MA; Gaisford S
Int J Pharm; 2011 Sep; 417(1-2):83-93. PubMed ID: 21277961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
